This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Randomised Trial of Anti-CD20 in C4d+ Chronic Allo...
Clinical trial

Randomised Trial of Anti-CD20 in C4d+ Chronic Allograft Nephropathy

Read time: 1 mins
Last updated:16th Oct 2006
To determine whether anti-CD20 therapy can stabilise or improve renal function and/or proteinuria in patients with C4d+, chronic (humoral) rejection in whom standard therapeutic approaches have failed.
Category Value
Study start date 2006-10-16

View full details